audit: verify timeline.ts against reference documents

Key corrections:
- HCD role: "Authored most" → "Wrote most" to match CV phrasing
- HCD role: "formulary adherence opportunities" → "improvement opportunities"
- Deputy Head: removed embellished description additions not in CV
- Duty Pharmacy Manager: "Led" → "Co-led" per secondary reference;
  removed national quality payments claim (belongs to Pharmacy Manager)
- Pre-Reg: aligned PGD and palliative care descriptions with secondary ref
- UEA MPharm: removed "academic excellence" (misleading given exam failures)

Updated unverified-content.md with corrections log and missed opportunities
including McDonald's role, Mary Seacole programme, self-taught coding
narrative, AI/LLM work, and opioid deprescribing metrics.

References/unverified-content.md

@@ -28,6 +28,14 @@ _Content modified to better align with reference documents._
 | File | Original | Corrected | Source |
 |------|----------|-----------|--------|
 | `src/data/patient.ts` | `address: 'Norwich, NR1'` | `address: 'Norwich, UK'` | CV_v4.md: "Norwich, UK" |
+| `src/data/timeline.ts` | HCD: "Authored most" | "Wrote most" | CV_v4.md: "Wrote most of the system's high-cost drug pathways" |
+| `src/data/timeline.ts` | HCD: "formulary adherence opportunities" | "improvement opportunities" | CV_v4.md: "identify improvement opportunities" |
+| `src/data/timeline.ts` | Deputy Head: added "monitor medicines safety" and extra sentence | Removed to match CV phrasing | CV_v4.md description is more concise |
+| `src/data/timeline.ts` | Duty Pharm Mgr: "Led NMS..." | "Co-led regional NMS..." | Secondary ref: "Co-led regional initiatives" |
+| `src/data/timeline.ts` | Duty Pharm Mgr: "Devised a quality payments solution adopted nationally" | Removed — belongs to Pharmacy Manager role | Secondary ref places national quality payments under Pharmacy Manager period |
+| `src/data/timeline.ts` | Pre-Reg: "Expanded PGD clinical services" | "Led initiation of Patient Group Directions" | Secondary ref: "Led initiation of PGDs" |
+| `src/data/timeline.ts` | Pre-Reg: "Developed a palliative care screening pathway" | "Provided clinical screening services for palliative care hospice" | Secondary ref: hospice clinical screening, not pathway development |
+| `src/data/timeline.ts` | UEA: "Demonstrated academic excellence" | "Achieved a distinction-grade research project and served as President of UEA Pharmacy Society" | Secondary ref: failed exams years 1-3, "academic excellence" misleading |
 
 ## Missed Opportunities
 
@@ -35,4 +43,11 @@ _Skills, projects, achievements, or goals from reference documents not yet repre
 
 | Source | Content | Potential Use |
 |--------|---------|---------------|
-| — | — | — |
+| Secondary ref | McDonald's Corporation role (Sep 2009 – Jun 2014) — Floor Manager, Crew Trainer & Crew Member | Early career leadership experience; could add as education-era entry |
+| Secondary ref | Mary Seacole Programme (NHS Leadership Academy, 78%, 2018) | NHS leadership qualification; currently missing from timeline |
+| Secondary ref | Failed pharmacy exams years 1-3 before completing degree | Powerful resilience narrative; could be added to MPharm description |
+| Secondary ref | Self-taught coding during Tesco night shifts (2017-2022) | Key narrative about technical skill origin; could enhance Pharmacy Manager entry |
+| Secondary ref | ADHD medication shortage guidance | Clinical leadership example during HCD role |
+| Secondary ref | UEA speaking engagements (2025) — "Careers in Data" and "Inspirational Roles in Pharmacy" panels | Public engagement and thought leadership |
+| Secondary ref | Opioid deprescribing evaluation: 18.3% decrease vs 6.9% national average | Strong quantified impact metric for CD monitoring system |
+| Secondary ref | AI/LLM work — fine-tuned 11B parameter model for prescription direction parsing | Technical capability demonstration |

src/data/timeline.ts

@@ -85,7 +85,7 @@ const timelineEntitySeeds: TimelineEntity[] = [
       startYear: 2024,
       endYear: null,
     },
-    description: 'Driving data analytics strategy for medicines optimisation, developing bespoke datasets and analytical frameworks from messy, real-world GP prescribing data to identify efficiency opportunities, monitor medicines safety, and address health inequalities across the integrated care system. Responsible for the analytical infrastructure underpinning all prescribing intelligence, from dm+d product data to population-level monitoring tools.',
+    description: 'Driving data analytics strategy for medicines optimisation, developing bespoke datasets and analytical frameworks from messy, real-world GP prescribing data to identify efficiency opportunities and address health inequalities across the integrated care system.',
     details: [
       'Managed £220M prescribing budget with sophisticated forecasting models identifying cost pressures and enabling proactive financial planning for ICB board reporting',
       'Collaborated with ICB data engineering to create a comprehensive dm+d medicines data table: standardised strength calculations, oral morphine equivalent conversions, and Anticholinergic Burden scoring, providing a single source of truth for all medicines analytics',
@@ -153,11 +153,11 @@ const timelineEntitySeeds: TimelineEntity[] = [
       startYear: 2022,
       endYear: 2024,
     },
-    description: 'Led implementation of NICE technology appraisals and high-cost drug pathways across the ICS. Authored most of the system\'s high-cost drug pathways spanning rheumatology, ophthalmology (wet AMD, DMO, RVO), dermatology, gastroenterology, neurology, and migraine, balancing the legal requirement to implement TAs against financial costs, formulary management, and local clinical preferences. Engaged clinical leads across primary care, secondary care, and commissioning to agree pathways and secure system-wide adoption.',
+    description: 'Led implementation of NICE technology appraisals and high-cost drug pathways across the ICS. Wrote most of the system\'s high-cost drug pathways spanning rheumatology, ophthalmology (wet AMD, DMO, RVO), dermatology, gastroenterology, neurology, and migraine — balancing legal requirements to implement TAs against financial costs and local clinical preferences. Engaged clinical leads across all sectors of care to agree pathways and secure system-wide adoption.',
     details: [
       'Developed software automating Blueteq prior authorisation form creation: 70% reduction in required forms, 200 hours immediate savings, and ongoing 7 to 8 hours weekly efficiency gains',
       'Integrated Blueteq data with secondary care activity databases, resolving critical data-matching limitations and enabling accurate high-cost drug spend tracking across the system',
-      'Created Python-based Sankey chart analysis tool visualising patient journeys through high-cost drug pathways, enabling trusts to audit compliance and identify formulary adherence opportunities',
+      'Created Python-based Sankey chart analysis tool visualising patient journeys through high-cost drug pathways, enabling trusts to audit compliance and identify improvement opportunities',
       'Negotiated pathway agreements with consultant clinical leads, GP prescribing leads, and pharmaceutical company representatives across multiple therapeutic areas',
     ],
     outcomes: [
@@ -259,20 +259,17 @@ const timelineEntitySeeds: TimelineEntity[] = [
       startYear: 2016,
       endYear: 2017,
     },
-    description: 'Provided clinical leadership and operational management across community pharmacy services at Tesco PLC in Great Yarmouth, progressing from newly qualified pharmacist to acting pharmacy manager within two months. Developed early expertise in service development, quality improvement, and the intersection of clinical practice and operational efficiency that would define the trajectory of the career ahead.',
+    description: 'Progressed from newly qualified pharmacist to acting pharmacy manager within two months at Tesco PLC in Great Yarmouth. Co-led regional initiatives for NMS and asthma referrals, developing resources supporting service provision across the region.',
     details: [
-      'Led NMS and asthma referral service development, improving uptake and patient outcomes',
+      'Co-led regional NMS and asthma referral service initiatives, developing resources adopted across 39 pharmacies in the region',
-      'Devised a quality payments solution adopted nationally across the Tesco pharmacy estate',
       'Built clinical foundation in medicines optimisation, patient safety, and community pharmacy operations',
     ],
     outcomes: [
-      'Service development leadership recognised regionally',
+      'Regional service development resources adopted across 39 pharmacies',
-      'National adoption of quality payments approach across Tesco estate',
       'Strong clinical grounding established for progression to pharmacy management',
     ],
     codedEntries: [
-      { code: 'SVC001', description: 'Service development: NMS and asthma referrals' },
+      { code: 'SVC001', description: 'Service development: NMS and asthma referrals, regional adoption' },
-      { code: 'INN002', description: 'Innovation: national quality payments solution' },
     ],
     skills: [
       'medicines-optimisation',
@@ -303,22 +300,22 @@ const timelineEntitySeeds: TimelineEntity[] = [
       startYear: 2015,
       endYear: 2016,
     },
-    description: 'Completed pre-registration training at Paydens Pharmacy across multiple community pharmacy sites in Tunbridge Wells and Ashford, Kent. Developed core clinical competencies and demonstrated initiative through expanding clinical services and delivering measurable quality improvements during the training year.',
+    description: 'Completed pre-registration training at Paydens Pharmacy across multiple community pharmacy sites in Tunbridge Wells and Ashford, Kent. Took on advanced responsibilities beyond typical pre-registration scope, including clinical service initiation and audit-driven process improvement.',
     details: [
-      'Expanded PGD clinical services: NRT, EHC, and chlamydia screening programmes across multiple Paydens branches',
+      'Led initiation of Patient Group Directions (PGDs) including NRT, emergency hormonal contraception, and chlamydia screening/treatment services',
-      'Improved NMS audit completion rate from under 10% to 50 to 60% through process redesign',
+      'Conducted comprehensive NMS audit, increasing completion rates from under 10% to 50 to 60% of target through process improvement',
-      'Developed a palliative care screening pathway for community pharmacy setting',
+      'Provided clinical screening services for palliative care hospice, gaining complex patient care and end-of-life medication management experience',
-      'Gained broad operational experience across multiple pharmacy sites',
+      'Developed understanding of wholesale procedures, regulatory compliance, and pharmacy business operations',
     ],
     outcomes: [
       'Successfully registered with GPhC in August 2016',
-      'Clinical service expansion adopted across multiple Paydens branches',
+      'Clinical service initiation adopted across multiple Paydens branches',
-      'Established reputation for quality improvement and proactive service development',
+      'Complex patient care experience gained through palliative care hospice work',
     ],
     codedEntries: [
       { code: 'PGD001', description: 'Clinical services: NRT, EHC, chlamydia PGDs' },
-      { code: 'AUD001', description: 'Audit: NMS completion under 10% to 50 to 60%' },
+      { code: 'AUD001', description: 'Audit: NMS completion under 10% to 50 to 60% of target' },
-      { code: 'PAL001', description: 'Palliative care: community screening pathway' },
+      { code: 'PAL001', description: 'Palliative care: hospice clinical screening services' },
     ],
     skills: [
       'medicines-optimisation',
@@ -345,7 +342,7 @@ const timelineEntitySeeds: TimelineEntity[] = [
       startYear: 2011,
       endYear: 2015,
     },
-    description: 'Completed four-year integrated Master of Pharmacy degree at the University of East Anglia, building a strong foundation in pharmaceutical sciences, clinical pharmacy, pharmacology, therapeutics, and research methodology. Demonstrated academic excellence through a distinction-grade research project and active engagement in university leadership.',
+    description: 'Completed four-year integrated Master of Pharmacy degree at the University of East Anglia, building a strong foundation in pharmaceutical sciences, clinical pharmacy, pharmacology, therapeutics, and research methodology. Achieved a distinction-grade research project and served as President of UEA Pharmacy Society.',
     details: [
       'Independent research project on drug delivery and cocrystals: 75.1% (Distinction)',
       '4th year OSCE: 80%',